Purchases and Sales Made in Q3 2024 in An2 Therapeutics, Inc. (ANTX)
This table provides information about the institutional ownership of An2 Therapeutics, Inc. (ANTX) during Q3 2024. The information is specifically focused on institutions that hold shares of AN2 Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 05, 2024
Q3 2024
|
Bml Capital Management, LLC
Zionsville, IN |
BUY
|
- |
5.75MNew |
$5.63M - $17M
|
5.75M
$8.62M
|
|
Nov 06, 2024
Q3 2024
|
Acuitas Investments, LLC
|
BUY
|
- |
446KNew |
$437K - $1.32M
|
446K
$669K
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
410K+ 2863.64% |
$401K - $1.21M
|
424K
$636K
|
|
Nov 13, 2024
Q3 2024
|
Aldebaran Capital, LLC
Indianapolis, IN |
BUY
|
- |
101KNew |
$98.5K - $297K
|
101K
$151K
|
|
Nov 14, 2024
Q3 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
92.7K+ 88.89% |
$90.9K - $274K
|
197K
$296K
|
|
Nov 14, 2024
Q3 2024
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
BUY
|
- |
79.4KNew |
$77.8K - $235K
|
79.4K
$119K
|
|
Oct 08, 2024
Q3 2024
|
Marquette Asset Management, LLC
|
BUY
|
- |
64.5KNew |
$63.2K - $191K
|
64.5K
$96.8K
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
45.8K+ 34.64% |
$44.8K - $135K
|
178K
$267K
|
|
Nov 14, 2024
Q3 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
BUY
|
- |
44.3K+ 203.57% |
$43.4K - $131K
|
66.1K
$99.2K
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
39.2K+ 21.69% |
$38.5K - $116K
|
220K
$330K
|
|
Nov 14, 2024
Q3 2024
|
Integrated Wealth Concepts LLC
|
BUY
|
- |
25KNew |
$24.5K - $74K
|
25K
$37.5K
|
|
Nov 14, 2024
Q3 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
23.7KNew |
$23.2K - $70K
|
23.7K
$35.5K
|
|
Nov 13, 2024
Q3 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
BUY
|
- |
2.09K+ 227.81% |
$2.05K - $6.18K
|
3.01K
$4.51K
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
574+ 3.67% |
$563 - $1.7K
|
16.2K
$24.3K
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-966- 94.71% |
$947 - $2.86K
|
54
$81
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.15K- 21.27% |
$1.13K - $3.4K
|
4.26K
$6.38K
|
|
Nov 14, 2024
Q3 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-13.8K- 10.24% |
$13.5K - $40.8K
|
121K
$181K
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-17.2K- 98.26% |
$16.8K - $50.8K
|
303
$455
|
|
Nov 12, 2024
Q3 2024
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-44.6K- 51.31% |
$43.7K - $132K
|
42.3K
$63.5K
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-128K- 24.4% |
$126K - $380K
|
398K
$597K
|
|
Nov 14, 2024
Q3 2024
|
Ra Capital Management, L.P.
Boston, MA |
SELL
|
- |
-3.55M- 63.97% |
$3.48M - $10.5M
|
2M
$3M
|